679 related articles for article (PubMed ID: 23143597)
1. The genetic landscape of mutations in Burkitt lymphoma.
Love C; Sun Z; Jima D; Li G; Zhang J; Miles R; Richards KL; Dunphy CH; Choi WW; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers CR; Naresh KN; Evens AM; Chadburn A; Gordon LI; Czader MB; Gill JI; Hsi ED; Greenough A; Moffitt AB; McKinney M; Banerjee A; Grubor V; Levy S; Dunson DB; Dave SS
Nat Genet; 2012 Dec; 44(12):1321-5. PubMed ID: 23143597
[TBL] [Abstract][Full Text] [Related]
2. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.
Richter J; Schlesner M; Hoffmann S; Kreuz M; Leich E; Burkhardt B; Rosolowski M; Ammerpohl O; Wagener R; Bernhart SH; Lenze D; Szczepanowski M; Paulsen M; Lipinski S; Russell RB; Adam-Klages S; Apic G; Claviez A; Hasenclever D; Hovestadt V; Hornig N; Korbel JO; Kube D; Langenberger D; Lawerenz C; Lisfeld J; Meyer K; Picelli S; Pischimarov J; Radlwimmer B; Rausch T; Rohde M; Schilhabel M; Scholtysik R; Spang R; Trautmann H; Zenz T; Borkhardt A; Drexler HG; Möller P; MacLeod RA; Pott C; Schreiber S; Trümper L; Loeffler M; Stadler PF; Lichter P; Eils R; Küppers R; Hummel M; Klapper W; Rosenstiel P; Rosenwald A; Brors B; Siebert R;
Nat Genet; 2012 Dec; 44(12):1316-20. PubMed ID: 23143595
[TBL] [Abstract][Full Text] [Related]
3. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
Gebauer N; Bernard V; Feller AC; Merz H
Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
[TBL] [Abstract][Full Text] [Related]
4. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
[TBL] [Abstract][Full Text] [Related]
5. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
[TBL] [Abstract][Full Text] [Related]
6. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.
O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS
Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858
[TBL] [Abstract][Full Text] [Related]
7. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
Zhang J; Jima D; Moffitt AB; Liu Q; Czader M; Hsi ED; Fedoriw Y; Dunphy CH; Richards KL; Gill JI; Sun Z; Love C; Scotland P; Lock E; Levy S; Hsu DS; Dunson D; Dave SS
Blood; 2014 May; 123(19):2988-96. PubMed ID: 24682267
[TBL] [Abstract][Full Text] [Related]
8. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.
Kretzmer H; Bernhart SH; Wang W; Haake A; Weniger MA; Bergmann AK; Betts MJ; Carrillo-de-Santa-Pau E; Doose G; Gutwein J; Richter J; Hovestadt V; Huang B; Rico D; Jühling F; Kolarova J; Lu Q; Otto C; Wagener R; Arnolds J; Burkhardt B; Claviez A; Drexler HG; Eberth S; Eils R; Flicek P; Haas S; Humme M; Karsch D; Kerstens HHD; Klapper W; Kreuz M; Lawerenz C; Lenzek D; Loeffler M; López C; MacLeod RAF; Martens JHA; Kulis M; Martín-Subero JI; Möller P; Nage I; Picelli S; Vater I; Rohde M; Rosenstiel P; Rosolowski M; Russell RB; Schilhabel M; Schlesner M; Stadler PF; Szczepanowski M; Trümper L; Stunnenberg HG; Küppers R; Ammerpohl O; Lichter P; Siebert R; Hoffmann S; Radlwimmer B
Nat Genet; 2015 Nov; 47(11):1316-1325. PubMed ID: 26437030
[TBL] [Abstract][Full Text] [Related]
9. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
[TBL] [Abstract][Full Text] [Related]
10. New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.
Greenough A; Dave SS
Curr Opin Hematol; 2014 Jul; 21(4):326-32. PubMed ID: 24867287
[TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity of diffuse large B-cell lymphoma.
Zhang J; Grubor V; Love CL; Banerjee A; Richards KL; Mieczkowski PA; Dunphy C; Choi W; Au WY; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers C; Naresh K; Evens A; Gordon LI; Czader M; Gill JI; Hsi ED; Liu Q; Fan A; Walsh K; Jima D; Smith LL; Johnson AJ; Byrd JC; Luftig MA; Ni T; Zhu J; Chadburn A; Levy S; Dunson D; Dave SS
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1398-403. PubMed ID: 23292937
[TBL] [Abstract][Full Text] [Related]
12. A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein.
Zajac-Kaye M; Gelmann EP; Levens D
Science; 1988 Jun; 240(4860):1776-80. PubMed ID: 2454510
[TBL] [Abstract][Full Text] [Related]
13. The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.
Wagener R; Aukema SM; Schlesner M; Haake A; Burkhardt B; Claviez A; Drexler HG; Hummel M; Kreuz M; Loeffler M; Rosolowski M; López C; Möller P; Richter J; Rohde M; Betts MJ; Russell RB; Bernhart SH; Hoffmann S; Rosenstiel P; Schilhabel M; Szczepanowski M; Trümper L; Klapper W; Siebert R; ;
Genes Chromosomes Cancer; 2015 Sep; 54(9):555-64. PubMed ID: 26173642
[TBL] [Abstract][Full Text] [Related]
14. The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas.
Soldini D; Georgis A; Montagna C; Schüffler PJ; Martin V; Curioni-Fontecedro A; Martinez A; Tinguely M
Hematol Oncol; 2014 Sep; 32(3):120-5. PubMed ID: 24493312
[TBL] [Abstract][Full Text] [Related]
15. New pathogenic mechanisms in Burkitt lymphoma.
Campo E
Nat Genet; 2012 Dec; 44(12):1288-9. PubMed ID: 23192177
[TBL] [Abstract][Full Text] [Related]
16. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
17. Sporadic and endemic Burkitt lymphoma have frequent
Zhou P; Blain AE; Newman AM; Zaka M; Chagaluka G; Adlar FR; Offor UT; Broadbent C; Chaytor L; Whitehead A; Hall A; O'Connor H; Van Noorden S; Lampert I; Bailey S; Molyneux E; Bacon CM; Bomken S; Rand V
Blood Adv; 2019 Jul; 3(14):2118-2127. PubMed ID: 31300419
[TBL] [Abstract][Full Text] [Related]
18. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
Ruzinova MB; Caron T; Rodig SJ
Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
[TBL] [Abstract][Full Text] [Related]
19. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.
Gonzalez-Farre B; Ramis-Zaldivar JE; Salmeron-Villalobos J; Balagué O; Celis V; Verdu-Amoros J; Nadeu F; Sábado C; Ferrández A; Garrido M; García-Bragado F; de la Maya MD; Vagace JM; Panizo CM; Astigarraga I; Andrés M; Jaffe ES; Campo E; Salaverria I
Haematologica; 2019 Sep; 104(9):1822-1829. PubMed ID: 30733272
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.
Burkhardt B; Michgehl U; Rohde J; Erdmann T; Berning P; Reutter K; Rohde M; Borkhardt A; Burmeister T; Dave S; Tzankov A; Dugas M; Sandmann S; Fend F; Finger J; Mueller S; Gökbuget N; Haferlach T; Kern W; Hartmann W; Klapper W; Oschlies I; Richter J; Kontny U; Lutz M; Maecker-Kolhoff B; Ott G; Rosenwald A; Siebert R; von Stackelberg A; Strahm B; Woessmann W; Zimmermann M; Zapukhlyak M; Grau M; Lenz G
Nat Commun; 2022 Jul; 13(1):3881. PubMed ID: 35794096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
